Neogen (NEOG) CEO updates Form 3 for indirect son-held share stakes
Rhea-AI Filing Summary
NEOGEN CORP CEO Nassif Mikheal filed an amended Form 3 reporting indirect holdings of company common shares held by his son. The amendment lists two indirect positions of 318 and 302 common shares as of August 11, 2025. A footnote states that Mikheal disclaims beneficial ownership of these securities, meaning he does not acknowledge them as his own holdings for Section 16 or other purposes.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Nassif Mikheal
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Holdings After Transaction:
Common Shares — 620 shares (Indirect, By son)
Footnotes (1)
- F1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Neogen (NEOG) Form 3/A filed by CEO Nassif Mikheal report?
The Form 3/A reports indirect holdings of Neogen common shares held by the CEO’s son. It lists two indirect positions of 318 and 302 shares as of August 11, 2025, and includes a disclaimer that the CEO does not admit beneficial ownership of these securities.
Why does the Neogen (NEOG) Form 3/A include a disclaimer of beneficial ownership?
The filing states that the reporting person disclaims beneficial ownership of the son-held shares. This means the CEO does not concede that these indirectly held securities are his for Section 16 or any other legal purpose, even though they are reported in the amended ownership statement.
Does the Neogen (NEOG) Form 3/A change the CEO’s direct ownership position?
The Form 3/A concerns indirect holdings and does not describe changes in direct ownership. It focuses on common shares held "By son" and clarifies, via footnote, that beneficial ownership of these securities is disclaimed, limiting their relevance to the CEO’s own reported stake.